|
22 Companies |
|
16 Products |
|
16 Products |
|
10 Mechanisms of Action |
|
3 Trials |
|
538 News |
|
| «123456789101112» |
- || Trial primary completion date: RAFIKI: A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention (clinicaltrials.gov) - Jan 29, 2015
P1, N=336, Recruiting, Sponsor: Brown University
Trial primary completion date: May 2016 --> Aug 2016
- || Trial primary completion date: Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy (clinicaltrials.gov) - Jan 22, 2015
P2, N=76, Active, not recruiting, Sponsor: Yale University
Trial primary completion date: May 2016 --> Aug 2016 Trial primary completion date: Dec 2014 --> Dec 2015
- Clinical: Impact of Alcohol Consumption on Use of Health Care Resources (clinicaltrials.gov) - Jan 22, 2015
P=N/A, N=1911771, Completed, Sponsor: Hospital Clinic of Barcelona
- | New P1/2 trial: Computerized Tool for Preventing Prenatal Drinking (clinicaltrials.gov) - Jan 13, 2015
P1/2, N=150, Not yet recruiting, Sponsor: Public Health Institute, California
- Trial completion: Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya (clinicaltrials.gov) - Jan 9, 2015
P=N/A, N=818, Completed, Sponsor: FHI 360
Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: Psychodynamic Therapy For Co-occurring Borderline Personality Disorder and Alcohol Use Disorder (clinicaltrials.gov) - Jan 6, 2015
P2, N=30, Completed, Sponsor: State University of New York - Upstate Medical University
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: May 2008 --> May 2010
- Clinical: Supportive Text Messages to Reduce Mood Symptoms and Problem Drinking- Randomised Controlled Pilot Trials (clinicaltrials.gov) - Dec 30, 2014
P=N/A, N=120, Not yet recruiting, Sponsor: University of Dublin, Trinity College
- Clinical: Alcohol Consumption and Gallbladder Cancer (clinicaltrials.gov) - Dec 30, 2014
P=N/A, N=156, Completed, Sponsor: Cheju Halla General Hospital
- Trial completion, Enrollment change: Retraining Attention to Treat Alcohol Dependence and Social Anxiety (clinicaltrials.gov) - Dec 17, 2014
P=N/A, N=115, Completed, Sponsor: University of Cincinnati
Active, not recruiting --> Completed | Trial primary completion date: May 2008 --> May 2010 Recruiting --> Completed | N=68 --> 115
- Biomarker, Enrollment open: Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol (clinicaltrials.gov) - Dec 14, 2014
P1, N=90, Recruiting, Sponsor: Parc de Salut Mar
Recruiting --> Completed | N=68 --> 115 Not yet recruiting --> Recruiting
- Enrollment open, Head-to-Head: EFAR-Spain: Primary Care-based Facilitated Access to a Web Based Brief Intervention to Reduce Alcohol Consumption (clinicaltrials.gov) - Dec 12, 2014
P=N/A, N=1000, Recruiting, Sponsor: Hospital Clinic of Barcelona
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- topiramate / Generic mfg.
Enrollment change, Trial initiation date, Trial primary completion date: TOPMRI: Topiramate's Effects on Heavy Drinking (clinicaltrials.gov) - Dec 10, 2014
P2, N=40, Not yet recruiting, Sponsor: University of Pennsylvania
Not yet recruiting --> Recruiting N=30 --> 40 | Initiation date: Feb 2014 --> Feb 2015 | Trial primary completion date: Sep 2019 --> Mar 2019
- Biomarker, New P1 trial: Non-oxidative Metabolite Profiles After Increasing Doses of Ethanol (clinicaltrials.gov) - Dec 8, 2014
P1, N=90, Recruiting, Sponsor: Parc de Salut Mar
- ||| Trial completion: The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS) (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=409, Completed, Sponsor: Stanford University
N=30 --> 40 | Initiation date: Feb 2014 --> Feb 2015 | Trial primary completion date: Sep 2019 --> Mar 2019 Active, not recruiting --> Completed
- Trial primary completion date: F-REDART: Formative Phase of Reducing Hazardous Alcohol Use & HIV Viral Load (clinicaltrials.gov) - Dec 6, 2014
P=N/A, N=40, Recruiting, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Trial primary completion date: Aug 2014 --> Aug 2015
- Enrollment change, Trial withdrawal: Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons (clinicaltrials.gov) - Dec 5, 2014
P2, N=0, Withdrawn, Sponsor: Mclean Hospital
Trial primary completion date: Aug 2014 --> Aug 2015 N=116 --> 0 | Not yet recruiting --> Withdrawn
- ||| Enrollment closed, Trial primary completion date: ABT-436 for Alcohol Dependence (clinicaltrials.gov) - Dec 5, 2014
P2, N=148, Active, not recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
N=116 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Feb 2015
- Enrollment closed: Integrating Substance Abuse Assessment & Intervention in Primary Care Settings (clinicaltrials.gov) - Nov 10, 2014
P=N/A, N=600, Active, not recruiting, Sponsor: Treatment Research Institute
Recruiting --> Active, not recruiting | Trial primary completion date: Oct 2014 --> Feb 2015 Recruiting --> Active, not recruiting
- Trial completion: Reducing Alcohol Use in Depressed Patients (clinicaltrials.gov) - Nov 7, 2014
P2, N=200, Completed, Sponsor: Rhode Island Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment open: PC: Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse (clinicaltrials.gov) - Nov 5, 2014
P=N/A, N=100, Recruiting, Sponsor: RAND
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Emergency Department (ED) Adolescent Alcohol Prevention Intervention (clinicaltrials.gov) - Nov 5, 2014
P=N/A, N=196, Completed, Sponsor: Rhode Island Hospital
Not yet recruiting --> Recruiting Recruiting --> Completed
- Enrollment open, Enrollment change, Trial initiation date, Trial primary completion date: Two Consecutive Randomized Controlled Trials Using Mobile Phone Applications for Risky Alcohol Use (clinicaltrials.gov) - Nov 4, 2014
P=N/A, N=2166, Enrolling by invitation, Sponsor: Karolinska Institutet
Recruiting --> Completed Not yet recruiting --> Enrolling by invitation | N=1000 --> 2166 | Initiation date: Mar 2014 --> Sep 2014 | Trial primary completion date: Aug 2014 --> Mar 2015
- Trial completion, Enrollment change, Trial primary completion date: Kudzu Treatment for Alcohol Abuse (clinicaltrials.gov) - Oct 22, 2014
P2, N=20, Completed, Sponsor: Mclean Hospital
Not yet recruiting --> Enrolling by invitation | N=1000 --> 2166 | Initiation date: Mar 2014 --> Sep 2014 | Trial primary completion date: Aug 2014 --> Mar 2015 Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: May 2015 --> May 2013
- Enrollment open: Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress (clinicaltrials.gov) - Oct 11, 2014
P1, N=66, Recruiting, Sponsor: Medical University of South Carolina
Recruiting --> Completed | N=30 --> 20 | Trial primary completion date: May 2015 --> May 2013 Not yet recruiting --> Recruiting
- |||| Selincro (nalmefene oral) / Lundbeck, Acorda
Enrollment open: Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro (clinicaltrials.gov) - Oct 10, 2014
P4, N=60, Recruiting, Sponsor: H. Lundbeck A/S
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- sodium valproate / Generic mfg., divalproex sodium XR / Generic mfg.
Trial primary completion date: Treatment Strategy for Alcohol Use Disorders in Veterans With TBI (clinicaltrials.gov) - Oct 4, 2014
P3, N=70, Recruiting, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Trial primary completion date: Jul 2014 --> Jun 2015
- | Trial completion: Addiction Health Evaluation And Disease Management (AHEAD) Study (clinicaltrials.gov) - Oct 2, 2014
P3, N=569, Completed, Sponsor: Boston Medical Center
Trial primary completion date: Jul 2014 --> Jun 2015 Active, not recruiting --> Completed
- ||||| Horizant (gabapentin enacarbil XR) / Azurity Pharma, Astellas, GSK
New P2 trial: HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder (clinicaltrials.gov) - Sep 30, 2014
P2, N=346, Not yet recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Enrollment open: Cognitive Retraining and Brain Stimulation for Alcohol Use (clinicaltrials.gov) - Sep 28, 2014
P=N/A, N=96, Recruiting, Sponsor: The Mind Research Network
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion, Enrollment change: Brief Interventions in the Emergency Department for Alcohol and HIV/Sexual Risk (clinicaltrials.gov) - Sep 15, 2014
P=N/A, N=400, Completed, Sponsor: Brown University
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | N=302 --> 400
- Enrollment change: SBIRT-PC: Screening, Brief Intervention, and Referral to Treatment in Primary Care (clinicaltrials.gov) - Sep 12, 2014
P=N/A, N=120, Recruiting, Sponsor: Duke University
Active, not recruiting --> Completed | N=302 --> 400 N=400 --> 120
- Trial completion, Phase classification, Enrollment change, Trial primary completion date: ReDIAL: A Telephone Brief Intervention for Injured Emergency Department Patients (clinicaltrials.gov) - Sep 11, 2014
P=N/A, N=730, Completed, Sponsor: Rhode Island Hospital
N=400 --> 120 Recruiting --> Completed | Phase classification: P2/3 --> PN/A | N=516 --> 730 | Trial primary completion date: Mar 2014 --> Mar 2013
- Enrollment change, Trial primary completion date: ALTAK: Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer (clinicaltrials.gov) - Aug 25, 2014
P=N/A, N=385, Active, not recruiting, Sponsor: Centre Oscar Lambret
Recruiting --> Completed | Phase classification: P2/3 --> PN/A | N=516 --> 730 | Trial primary completion date: Mar 2014 --> Mar 2013 N=750 --> 385 | Trial primary completion date: Sep 2014 --> Sep 2013
- Trial completion, Trial primary completion date: Examining Common Substrates of Eating and Alcohol Use Disorders (clinicaltrials.gov) - Aug 21, 2014
P=N/A, N=61, Completed, Sponsor: New York State Psychiatric Institute
N=750 --> 385 | Trial primary completion date: Sep 2014 --> Sep 2013 Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014
- || Trial primary completion date: ABT-436 for Alcohol Dependence (clinicaltrials.gov) - Aug 12, 2014
P2, N=148, Recruiting, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Recruiting --> Completed | Trial primary completion date: Dec 2013 --> Jun 2014 Trial primary completion date: Jun 2014 --> Oct 2014
- New P2 trial: Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence (clinicaltrials.gov) - Aug 6, 2014
P2, N=40, Recruiting, Sponsor: The Scripps Research Institute
- Trial completion: Computer-delivered Screening and Brief Intervention for Alcohol Use in Pregnancy (clinicaltrials.gov) - Aug 1, 2014
P1, N=48, Completed, Sponsor: Wayne State University
Trial primary completion date: Jun 2014 --> Oct 2014 Recruiting --> Completed
- ||| Adomet (S-adenosyl-L-methionine) / Abbott
New P3 trial: Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption (clinicaltrials.gov) - Jul 27, 2014
P3, N=50, Recruiting, Sponsor: Abbott
- Trial completion, Enrollment change: Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects (clinicaltrials.gov) - Jul 24, 2014
P1, N=40, Completed, Sponsor: Parc de Salut Mar
Recruiting --> Completed Active, not recruiting --> Completed | N=56 --> 40
- ||||| Selincro (nalmefene oral) / Lundbeck, Acorda
New P4 trial: Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro (clinicaltrials.gov) - Jul 23, 2014
P4, N=60, Not yet recruiting, Sponsor: H. Lundbeck A/S
- Trial initiation date: Tailored Mobile Text Messaging to Reduce Problem Drinking (clinicaltrials.gov) - Jul 18, 2014
P=N/A, N=300, Recruiting, Sponsor: Research Foundation for Mental Hygiene, Inc.
Active, not recruiting --> Completed | N=56 --> 40 Initiation date: Aug 2013 --> Feb 2014
- Surgery: STOP-OP: Intensive Smoking and Alcohol Cessation Intervention in Bladder Cancer Surgery Patients (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=160, Not yet recruiting, Sponsor: Rigshospitalet, Denmark
- Clinical: Project Relay Model for Recruiting Alcohol Dependent Patients in General Hospitals (clinicaltrials.gov) - Jul 12, 2014
P=N/A, N=1000, Recruiting, Sponsor: University of Southern Denmark
- Trial completion, Enrollment change: CHOICE: Brief Voluntary Alcohol and Drug Intervention for Middle School Youth (clinicaltrials.gov) - Jul 12, 2014
P2, N=6455, Completed, Sponsor: RAND
Initiation date: Aug 2013 --> Feb 2014 Active, not recruiting --> Completed | N=11000 --> 6455
- Chantix (varenicline) / Pfizer
Trial completion: Varenicline to Reduce Alcohol Consumption in Heavy Drinkers (clinicaltrials.gov) - Jul 12, 2014
P1/2, N=50, Completed, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Completed | N=11000 --> 6455 Active, not recruiting --> Completed
- mirtazapine / Generic mfg.
New P2 trial: PT-MAD: Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. (clinicaltrials.gov) - Jul 10, 2014
P2, N=32, Recruiting, Sponsor: University of Pittsburgh
- Trial primary completion date: Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans (clinicaltrials.gov) - Jul 8, 2014
P0, N=18, Completed, Sponsor: Yale University
Active, not recruiting --> Completed Trial primary completion date: Dec 2011 --> Jun 2010
- Enrollment change: Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans (clinicaltrials.gov) - Jul 8, 2014
P0, N=18, Completed, Sponsor: Yale University
Trial primary completion date: Dec 2011 --> Jun 2010 N=34 --> 18
- Phase classification: Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans (clinicaltrials.gov) - Jul 8, 2014
P0, N=18, Completed, Sponsor: Yale University
N=34 --> 18 Phase classification: P=N/A --> P0
- naltrexone / Generic mfg.
Enrollment open, Compliance: Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder (clinicaltrials.gov) - Jul 8, 2014
P4, N=152, Recruiting, Sponsor: Fred Hutchinson Cancer Research Center
Phase classification: P=N/A --> P0 Not yet recruiting --> Recruiting